Pharmaceutical & API manufacturing sites in Brazil

30 drug establishments in Brazil are registered with the US FDA; 11 (37%) list API manufacture among their operations. 27 registrant companies are identified, 1 of them with more than one API site here; sites whose registrant is not resolved to a company profile are not counted. 3 published sites are matched to an EU or UK GMP certificate inspected within the last three years.

Counts are physical site addresses in the FDA's current establishment register (US-facing sites only), not headquarters and not production volume. Methodology

FDA-registered sites
30
Registered for API manufacture
11
Identified registrants
27
Current EU/UK GMP match
3

Only sites registered with the US FDA appear, so manufacturing that serves only other markets is missing and these figures understate national capacity. A GMP match requires the certificate address to name the site's street and its city or postcode; an unmatched site is not an uncertified site.